344 related articles for article (PubMed ID: 26582071)
1. Novel avenues in immunotherapies for colorectal cancer.
Pardieck IN; Jawahier PA; Swets M; van de Velde CJ; Kuppen PJ
Expert Rev Gastroenterol Hepatol; 2016; 10(4):465-80. PubMed ID: 26582071
[TBL] [Abstract][Full Text] [Related]
2. A Role for MAIT Cells in Colorectal Cancer.
Berzins SP; Wallace ME; Kannourakis G; Kelly J
Front Immunol; 2020; 11():949. PubMed ID: 32508830
[TBL] [Abstract][Full Text] [Related]
3. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
Roelands J; Kuppen PJK; Vermeulen L; Maccalli C; Decock J; Wang E; Marincola FM; Bedognetti D; Hendrickx W
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064420
[TBL] [Abstract][Full Text] [Related]
4. Single-cell immune profiling reveals new insights into colorectal cancer.
Lönnberg T; Stubbington MJ
Immunol Cell Biol; 2019 Mar; 97(3):241-243. PubMed ID: 30791147
[No Abstract] [Full Text] [Related]
5. High-resolution genomic analysis: the tumor-immune interface comes into focus.
Havel JJ; Chan TA
Genome Biol; 2015 Mar; 16(1):65. PubMed ID: 25853850
[TBL] [Abstract][Full Text] [Related]
6. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
Guo L; Wang C; Qiu X; Pu X; Chang P
Front Immunol; 2020; 11():1052. PubMed ID: 32547556
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for colorectal cancer.
Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
[TBL] [Abstract][Full Text] [Related]
8. Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.
Malvicini M; Fiore E; Ghiaccio V; Piccioni F; Rizzo M; Olmedo Bonadeo L; García M; Rodríguez M; Bayo J; Peixoto E; Atorrasagasti C; Alaniz L; Aquino J; Matar P; Mazzolini G
Mol Ther; 2015 Sep; 23(9):1444-55. PubMed ID: 26105158
[TBL] [Abstract][Full Text] [Related]
9. [Going beyond microsatellite instability for immunotherapy in metastatic colorectal cancer: Consensus molecular subtypes and tumor mutational burden].
Cohen R; Heran M; Pudlarz T; Hilmi M; Tournigand C; André T; Rousseau B
Bull Cancer; 2019 Feb; 106(2):151-161. PubMed ID: 30638897
[TBL] [Abstract][Full Text] [Related]
10. [Immune response and colorectal cancer].
Tougeron D; Fauquembergue E; Latouche JB
Bull Cancer; 2013 Mar; 100(3):283-94. PubMed ID: 23501583
[TBL] [Abstract][Full Text] [Related]
11. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
Hope C; Emmerich PB; Papadas A; Pagenkopf A; Matkowskyj KA; Van De Hey DR; Payne SN; Clipson L; Callander NS; Hematti P; Miyamoto S; Johnson MG; Deming DA; Asimakopoulos F
J Immunol; 2017 Sep; 199(5):1933-1941. PubMed ID: 28754680
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy.
Angelova M; Charoentong P; Hackl H; Fischer ML; Snajder R; Krogsdam AM; Waldner MJ; Bindea G; Mlecnik B; Galon J; Trajanoski Z
Genome Biol; 2015 Mar; 16(1):64. PubMed ID: 25853550
[TBL] [Abstract][Full Text] [Related]
13. The potential role of immunotherapy to treat colorectal cancer.
Amin M; Lockhart AC
Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
[TBL] [Abstract][Full Text] [Related]
14. Immune Therapy in GI Malignancies: A Review.
Wang J; Reiss KA; Khatri R; Jaffee E; Laheru D
J Clin Oncol; 2015 Jun; 33(16):1745-53. PubMed ID: 25918295
[TBL] [Abstract][Full Text] [Related]
15. Genomics and emerging biomarkers for immunotherapy of colorectal cancer.
Kather JN; Halama N; Jaeger D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):189-197. PubMed ID: 29501787
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers.
Kikuchi T; Mimura K; Ashizawa M; Okayama H; Endo E; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Shimada K; Yoshimura K; Tsunoda T; Kono K
Cancer Immunol Immunother; 2020 Jan; 69(1):23-32. PubMed ID: 31768581
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy.
IJsselsteijn ME; Sanz-Pamplona R; Hermitte F; de Miranda NFCC
Mol Aspects Med; 2019 Oct; 69():123-129. PubMed ID: 31136750
[TBL] [Abstract][Full Text] [Related]
18. An update on colorectal cancer microenvironment, epigenetic and immunotherapy.
Jin K; Ren C; Liu Y; Lan H; Wang Z
Int Immunopharmacol; 2020 Dec; 89(Pt A):107041. PubMed ID: 33045561
[TBL] [Abstract][Full Text] [Related]
19. Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape.
Sun XG; Lin XC; Diao JX; Yu ZL; Li K
Chin J Integr Med; 2016 Oct; 22(10):789-94. PubMed ID: 26556710
[TBL] [Abstract][Full Text] [Related]
20. [Immune response and digestive cancers: Prognostic and therapeutic implications].
Bibeau F; Bazille C; Svrcek M; Pierson R; Lagorce-Pagès C; Cohen R; André T
Ann Pathol; 2017 Feb; 37(1):111-116. PubMed ID: 28111038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
